Overall, these results show an early increase in IFN-γ responses by lymph node cells of PD-1 antibody-treated mice to a lesion or tumor challenge, but a diminished inflammatory cytokine response which, instead, is more prominent for lymph node cells of control antibody-treated mice. The gene discussed is PDCD1; the disease is neoplasm.